News

Rokiskio Suris Group Report Highlights for 2024

Rokiskio Suris Group Report Highlights for 2024

Rokiskio Suris Group Reports Impressive Results for the First Half of 2024

In the first half of 2024, Rokiskio suris AB Group has demonstrated outstanding financial performance, achieving consolidated unaudited sales of EUR 174,808 thousand. This marks an 18% increase from EUR 148,106 thousand in the same period last year, showcasing a strong performance in a competitive market landscape.

Notable Increase in Net Profit

From January to June, Rokiskio suris AB Group reported a net profit of EUR 6,429 thousand, resulting in a net profitability of 3.68%. This represents a significant rise from last year's net profit of EUR 1,794 thousand, underscoring the Group's successful strategies in enhancing profitability.

Insights into EBITDA Performance

The EBITDA, which stands for earnings before interest, taxes, depreciation, and amortization, also experienced a significant increase. In the first half of 2024, EBITDA reached EUR 13,710 thousand, a notable improvement from EUR 6,615 thousand reported during the same period in 2023. This growth reflects enhanced operational efficiency and effective cost management.

Key Factors Behind Revenue Growth

The impressive rise in Rokiskio suris AB Group's operating results can be linked to increasing prices for fresh and GRAND fermented cheeses, as well as other whey products and fats. These price hikes have positively influenced the Group's profitability and competitive positioning in the market during the first half of 2024.

Future Outlook

These results indicate that Rokiskio suris AB Group is on a promising path as it continues to adapt and excel in its industry. The focus on product pricing adjustments and quality enhancement has laid a solid groundwork for future success, and stakeholders can anticipate ongoing growth in the upcoming quarters.

Contact Information

For additional details or inquiries, please reach out to:

Dalius Trumpa, CEO
+370 458 55200

Frequently Asked Questions

What are the main achievements of Rokiskio Suris Group in 2024?

Rokiskio Suris Group achieved a significant increase in sales by 18%, reaching EUR 174,808 thousand, along with a net profit of EUR 6,429 thousand.

How did Rokiskio Suris Group's EBITDA change in the first half of 2024?

The EBITDA rose to EUR 13,710 thousand in the first half of 2024, a substantial increase compared to EUR 6,615 thousand in the same period last year.

What factors contributed to Rokiskio Suris Group's revenue growth?

The increase in revenue was largely driven by higher prices for fresh and GRAND fermented cheeses and other whey products and fats.

Who is the CEO of Rokiskio Suris Group, and how can I contact them?

The CEO of Rokiskio Suris Group is Dalius Trumpa. You can contact him at +370 458 55200.

Where can I find the full interim report?

The full interim report can be accessed directly through the company’s announcements and financial disclosures.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Coca-Cola's Recent Unusual Options Trends

Updated Category News Views 259

Analyzing Coca-Cola's Recent Options Activity Investors are showing a bearish trend toward Coca-Cola (KO), which is an important indicator for retail traders monitoring investment trends. The recent unusual options activity suggests that these investors may possess insights not yet shared with the public. Thus, individual traders should be particularly attentive to these...

Continue Reading
Sustainable Palm Oil Market Growth Driven by AI Insights

Updated Category News Views 136

Exploring the Growth of the Sustainable Palm Oil Market The sustainable palm oil market is currently on the rise, fueled by a growing demand for trans-fat-free products and innovations in eco-friendly farming practices. This growth is expected to hit around USD 2.75 billion by 2028, reflecting a solid compound annual growth rate (CAGR) of about 5.24% in the coming years....

Continue Reading
Grilling Safety Tips from Ferrellgas This Labor Day

Updated Category News Views 82

Grilling Safety Tips from Ferrellgas This Labor Day As we gear up for one of the biggest grilling holidays of the year, it's essential to keep safety in mind while savoring delicious meals with family and friends. Ferrellgas Partners, L.P. is taking this opportunity to remind customers about the significance of safe grilling practices this Labor Day. This holiday not only...

Continue Reading
Solstice Gold Secures Funding Through Successful Placement Deal

Updated Category News Views 127

Solstice Gold Completes Successful Private Placement Financing Solstice Gold Corp. (“Solstice”, “we”, “our”, or the “Company”) is thrilled to announce the successful closing of its private placement financing. This significant financial milestone comes with gross proceeds of approximately $150,000 from the issuance of 6,600,000 shares. This private...

Continue Reading
Avanos Medical Introduces Innovative CORGRIP SR System

Updated Category News Views 32

Avanos Medical Launches New CORGRIP SR Advancement to reduce dislodgement in feeding tube retention systems Avanos Medical, Inc. (NYSE: AVNS) recently announced an exciting development in its Enteral Feeding portfolio with the launch of the CORGRIP SR Nasogastric/Nasointestinal Tube Retention System. This innovative design aims to provide enhanced support and security for...

Continue Reading